Reaction Details Report a problem with these data
Target
Ceramide glucosyltransferase
Ligand
BDBM367626
Substrate
n/a
Meas. Tech.
GCS Enzymatic Assay
IC50
55±n/a nM
Citation
 Wang, B Glucosylceramide synthase inhibitors for the treatment of diseases US Patent  US10227312 Publication Date 3/12/2019 
Target
Name:
Ceramide glucosyltransferase
Synonyms:
CEGT_HUMAN | GCS | GLCT-1 | Glucosylceramide synthase | UDP-glucose ceramide glucosyltransferase | UDP-glucose:N-acylsphingosine D-glucosyltransferase | UGCG
Type:
PROTEIN
Mol. Mass.:
44859.25
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1435474
Residue:
394
Sequence:
MALLDLALEGMAVFGFVLFLVLWLMHFMAIIYTRLHLNKKATDKQPYSKLPGVSLLKPLKGVDPNLINNLETFFELDYPKYEVLLCVQDHDDPAIDVCKKLLGKYPNVDARLFIGGKKVGINPKINNLMPGYEVAKYDLIWICDSGIRVIPDTLTDMVNQMTEKVGLVHGLPYVADRQGFAATLEQVYFGTSHPRYYISANVTGFKCVTGMSCLMRKDVLDQAGGLIAFAQYIAEDYFMAKAIADRGWRFAMSTQVAMQNSGSYSISQFQSRMIRWTKLRINMLPATIICEPISECFVASLIIGWAAHHVFRWDIMVFFMCHCLAWFIFDYIQLRGVQGGTLCFSKLDYAVAWFIRESMTIYIFLSALWDPTISWRTGRYRLRCGGTAEEILDV
  
Inhibitor
Name:
BDBM367626
Synonyms:
N-((1R,2R)-3-(azetidin-1-yl)-1-(4- cyclopropoxyphenyl)-1-hydroxypropan- 2-yl)-7-(5-chlorothiophen-2-yl)-1H- benzo[d][1,2]oxazine-4-carboxamide | US10227312, Example 11 | US10759769, Example 11
Type:
Small organic molecule
Emp. Form.:
C28H28ClN3O4S
Mol. Mass.:
538.058
SMILES:
O[C@@H]([C@@H](CN1CCC1)NC(=O)C1=NOCc2cc(ccc12)-c1ccc(Cl)s1)c1ccc(OC2CC2)cc1 |r,t:12|
Structure:
Search PDB for entries with ligand similarity: